On the public citation graph

Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry

https://doi.org/10.1007/s00296-021-04819-1

0 signed · 224 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/acr.21728openalex-snapshot

Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti–melanoma differentiation–associated gene 5 antibody

inferredcites →https://doi.org/10.1002/acr.21985openalex-snapshot

Utility of Anti–Melanoma Differentiation–Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta‐Analysis

inferredcites →https://doi.org/10.1002/acr.21992openalex-snapshot

Anti–Melanoma Differentiation–Associated Protein 5–Associated Dermatomyositis: Expanding the Clinical Spectrum

inferredcites →https://doi.org/10.1002/acr.22498openalex-snapshot

Cutaneous Ulceration in Dermatomyositis: Association With Anti–Melanoma Differentiation–Associated Gene 5 Antibodies and Interstitial Lung Disease

inferredcites →https://doi.org/10.1002/acr.22728openalex-snapshot

Anti–Melanoma Differentiation–Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis

inferredcites →https://doi.org/10.1002/art.1780291109openalex-snapshot

PREVALENCE OF COXSACKIE B VIRUS ANTIBODIES IN PATIENTS WITH JUVENILE DERMATOMYOSITIS

inferredcites →https://doi.org/10.1002/art.21023openalex-snapshot

Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositis

inferredcites →https://doi.org/10.1002/art.24621openalex-snapshot

RNA helicase encoded by melanoma differentiation–associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

inferredcites →https://doi.org/10.1002/art.34657openalex-snapshot

Brief Report: Association of HLA–DRB1*0101/*0405 with susceptibility to anti–melanoma differentiation–associated gene 5 antibody–positive dermatomyositis in the Japanese population

inferredcites →https://doi.org/10.1002/art.41105openalex-snapshot

Multicenter Prospective Study of the Efficacy and Safety of Combined Immunosuppressive Therapy With High‐Dose Glucocorticoid, Tacrolimus, and Cyclophosphamide in Interstitial Lung Diseases Accompanied by Anti–Melanoma Differentiation–Associated Gene 5–Positive Dermatomyositis

inferredcites →https://doi.org/10.1002/jca.21833openalex-snapshot

Anti‐MDA ‐5 antibody‐positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: A case series

inferredcites →https://doi.org/10.1002/jcla.22978openalex-snapshot

Serum KL‐6 level is a prognostic marker in patients with anti‐MDA5 antibody‐positive dermatomyositis associated with interstitial lung disease

inferredcites →https://doi.org/10.1002/rcr2.235openalex-snapshot

Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate

inferredcites →https://doi.org/10.1007/s00296-011-1999-3openalex-snapshot

Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors

inferredcites →https://doi.org/10.1007/s00296-011-2323-yopenalex-snapshot

Anti-MDA5 antibody is associated with A/SIP and decreased T cells in peripheral blood and predicts poor prognosis of ILD in Chinese patients with dermatomyositis

inferredcites →https://doi.org/10.1007/s00296-017-3707-4openalex-snapshot

Autoantibodies in children with juvenile dermatomyositis: A single centre experience from North-West India

inferredcites →https://doi.org/10.1007/s00296-019-04255-2openalex-snapshot

Liver dysfunction in anti-melanoma differentiation-associated gene 5 antibody-positive patients with dermatomyositis

inferredcites →https://doi.org/10.1007/s00296-019-04398-2openalex-snapshot

Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review

inferredcites →https://doi.org/10.1007/s00296-020-04590-9openalex-snapshot

Macrophage activation syndrome in adult dermatomyositis: a case-based review

inferredcites →https://doi.org/10.1007/s00296-020-04695-1openalex-snapshot

Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians

inferredcites →https://doi.org/10.1007/s00296-020-04737-8openalex-snapshot

Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic

inferredcites →https://doi.org/10.1007/s10067-012-2142-xopenalex-snapshot

Limitations of a single-point evaluation of anti-MDA5 antibody, ferritin, and IL-18 in predicting the prognosis of interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

inferredcites →https://doi.org/10.1007/s10067-015-3001-3openalex-snapshot

Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum

inferredcites →https://doi.org/10.1007/s10067-018-4122-2openalex-snapshot

Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis

inferredcites →https://doi.org/10.1007/s10067-019-04729-5openalex-snapshot

Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum

inferredcites →https://doi.org/10.1007/s10067-019-04918-2openalex-snapshot

Noninvasive positive pressure ventilator deteriorates the outcome of pneumomediastinum in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis

inferredcites →https://doi.org/10.1007/s10067-020-05339-2openalex-snapshot

Hierarchical cluster analysis of cytokine profiles reveals a cutaneous vasculitis-associated subgroup in dermatomyositis

inferredcites →https://doi.org/10.1007/s10165-010-0371-xopenalex-snapshot

Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis

inferredcites →https://doi.org/10.1007/s11926-018-0798-1openalex-snapshot

Anti-MDA5 Antibody Spectrum in Western World

inferredcites →https://doi.org/10.1016/j.ajpath.2015.11.010openalex-snapshot

Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies

inferredcites →https://doi.org/10.1016/j.autrev.2020.102666openalex-snapshot

What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?

inferredcites →https://doi.org/10.1016/j.chest.2020.04.057openalex-snapshot

Mortality Risk Prediction in Amyopathic Dermatomyositis Associated With Interstitial Lung Disease

inferredcites →https://doi.org/10.1016/j.jaad.2010.09.016openalex-snapshot

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study

inferredcites →https://doi.org/10.1016/j.jaad.2017.12.010openalex-snapshot

Anti-melanoma differentiation–associated gene 5 (MDA5) dermatomyositis: A concise review with an emphasis on distinctive clinical features

inferredcites →https://doi.org/10.1016/j.jaut.2019.04.001openalex-snapshot

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

inferredcites →https://doi.org/10.1016/j.jpeds.2010.11.033openalex-snapshot

Anti-Melanoma Differentiation-Associated Gene 5 Antibody is a Diagnostic and Predictive Marker for Interstitial Lung Diseases Associated with Juvenile Dermatomyositis

inferredcites →https://doi.org/10.1016/j.jtauto.2019.100013openalex-snapshot

Frequencies and clinical associations of myositis-related antibodies in The Netherlands: A one-year survey of all Dutch patients

inferredcites →https://doi.org/10.1016/j.rmcr.2016.11.015openalex-snapshot

Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy

inferredcites →https://doi.org/10.1016/j.rmed.2011.05.006openalex-snapshot

HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody

inferredcites →https://doi.org/10.1016/j.rmed.2015.07.004openalex-snapshot

Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody positive amyopathic dermatomyositis

inferredcites →https://doi.org/10.1016/j.rmed.2020.105983openalex-snapshot

Ultra-low dose rituximab as add-on therapy in anti-MDA5-positive patients with polymyositis /dermatomyositis associated ILD

inferredcites →https://doi.org/10.1016/j.rmed.2020.106134openalex-snapshot

Anti-Ro52 antibody is an independent risk factor for interstitial lung disease in dermatomyositis

inferredcites →https://doi.org/10.1016/j.semarthrit.2020.03.007openalex-snapshot

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease

inferredcites →https://doi.org/10.1016/j.tim.2018.08.007openalex-snapshot

A Balancing Act: MDA5 in Antiviral Immunity and Autoinflammation

inferredcites →https://doi.org/10.1016/s2213-2600(20)30243-5openalex-snapshot

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans

inferredcites →https://doi.org/10.1038/nrrheum.2018.56openalex-snapshot

Autoantibodies in myositis

inferredcites →https://doi.org/10.1038/s41598-020-72752-7openalex-snapshot

The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease

inferredcites →https://doi.org/10.1038/srep33226openalex-snapshot

Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis

inferredcites →https://doi.org/10.1056/nejm197502132920706openalex-snapshot

Polymyositis and Dermatomyositis

inferredcites →https://doi.org/10.1056/nejm197502202920807openalex-snapshot

Polymyositis and Dermatomyositis

inferredcites →https://doi.org/10.1056/nejmc1900045openalex-snapshot

Tofacitinib in Amyopathic Dermatomyositis–Associated Interstitial Lung Disease

inferredcites →https://doi.org/10.1073/pnas.022637199openalex-snapshot

mda-5 : An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties

inferredcites →https://doi.org/10.1080/03009740802687455openalex-snapshot

Association of distinct clinical subsets with myositis‐specific autoantibodies towards anti‐155/140‐kDa polypeptides, anti‐140‐kDa polypeptides, and anti‐aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single‐centre, cross‐sectional study

inferredcites →https://doi.org/10.1080/03009742.2019.1653493openalex-snapshot

Three cases of autoimmune-associated haemophagocytic syndrome in dermatomyositis with anti-MDA5 autoantibody

inferredcites →https://doi.org/10.1080/14397595.2018.1452179openalex-snapshot

Improved quantification of a commercial enzyme-linked immunosorbent assay kit for measuring anti-MDA5 antibody

inferredcites →https://doi.org/10.1080/14397595.2018.1511025openalex-snapshot

Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan

inferredcites →https://doi.org/10.1080/14397595.2018.1548918openalex-snapshot

Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis

inferredcites →https://doi.org/10.1080/14397595.2020.1740400openalex-snapshot

Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age

inferredcites →https://doi.org/10.1093/rheumatology/39.9.1037openalex-snapshot

Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle

inferredcites →https://doi.org/10.1093/rheumatology/keaa033openalex-snapshot

The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients

inferredcites →https://doi.org/10.1093/rheumatology/keaa034openalex-snapshot

Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis

inferredcites →https://doi.org/10.1093/rheumatology/keaa123openalex-snapshot

Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment

inferredcites →https://doi.org/10.1093/rheumatology/keaa429openalex-snapshot

Anti-MDA5 autoantibodies associated with juvenile dermatomyositis constitute a distinct phenotype in North America

inferredcites →https://doi.org/10.1093/rheumatology/keaa610openalex-snapshot

COVID-19 and myositis – unique challenges for patients

inferredcites →https://doi.org/10.1093/rheumatology/keaa821openalex-snapshot

Psoriasiform rashes as the first manifestation of anti-MDA5 associated myositis

inferredcites →https://doi.org/10.1093/rheumatology/keab001openalex-snapshot

High early mortality in idiopathic inflammatory myopathies: results from the inception cohort at a tertiary care centre in northern India

inferredcites →https://doi.org/10.1093/rheumatology/kep375openalex-snapshot

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

inferredcites →https://doi.org/10.1093/rheumatology/keq149openalex-snapshot

Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

inferredcites →https://doi.org/10.1093/rheumatology/keq153openalex-snapshot

Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis

inferredcites →https://doi.org/10.1093/rheumatology/ker518openalex-snapshot

The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM

inferredcites →https://doi.org/10.1093/rheumatology/kes102openalex-snapshot

Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

inferredcites →https://doi.org/10.1093/rheumatology/keu385openalex-snapshot

Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis

inferredcites →https://doi.org/10.1093/rheumatology/key060openalex-snapshot

Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients

inferredcites →https://doi.org/10.1093/rheumatology/key188openalex-snapshot

Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis

inferredcites →https://doi.org/10.1093/rheumatology/key386openalex-snapshot

The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients

inferredcites →https://doi.org/10.1093/rheumatology/kez185openalex-snapshot

Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD

inferredcites →https://doi.org/10.1093/rheumatology/kez357openalex-snapshot

Successful treatment of anti-MDA5 antibody-positive refractory interstitial lung disease with plasma exchange therapy

inferredcites →https://doi.org/10.1093/rheumatology/kez525openalex-snapshot

Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signalling

inferredcites →https://doi.org/10.1097/bor.0000000000000749openalex-snapshot

Monitoring disease activity and damage in adult and juvenile idiopathic inflammatory myopathy

inferredcites →https://doi.org/10.1097/md.0000000000015578openalex-snapshot

Clinical significance of myositis-specific autoantibody profiles in Japanese patients with polymyositis/dermatomyositis

inferredcites →https://doi.org/10.1097/md.0000000000021943openalex-snapshot

Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission

inferredcites →https://doi.org/10.1097/rhu.0000000000001114openalex-snapshot

Successful Treatment of Anti-MDA5 Dermatomyositis Associated Cutaneous Digital Pulp Ulcerations With Hyperbaric Oxygen Therapy

inferredcites →https://doi.org/10.1097/rhu.0000000000001191openalex-snapshot

Polymyxin-B Hemoperfusion as a Novel Treatment for Rapidly Progressive Interstitial Lung Disease in a Pediatric Patient Diagnosed With Anti-MDA5 Juvenile Dermatomyositis

inferredcites →https://doi.org/10.1111/1346-8138.15117openalex-snapshot

Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease

inferredcites →https://doi.org/10.1111/1346-8138.15274openalex-snapshot

Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti‐melanoma differentiation‐associated gene 5 antibody‐positive dermatomyositis

inferredcites →https://doi.org/10.1111/bjd.14882openalex-snapshot

Antimelanoma differentiation‐associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis

inferredcites →https://doi.org/10.1111/bjd.16917openalex-snapshot

Aberrant activation of the type I interferon system may contribute to the pathogenesis of anti‐melanoma differentiation‐associated gene 5 dermatomyositis

inferredcites →https://doi.org/10.1111/cei.13404openalex-snapshot

A high level of serum neopterin is associated with rapidly progressive interstitial lung disease and reduced survival in dermatomyositis

inferredcites →https://doi.org/10.1111/j.1365-2133.2012.11145.xopenalex-snapshot

Dysregulation of the type I interferon system in adult‐onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease

inferredcites →https://doi.org/10.1111/nan.12528openalex-snapshot

Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features

inferredcites →https://doi.org/10.1136/annrheumdis-2014-205278openalex-snapshot

Basiliximab may improve the survival rate of rapidly progressive interstitial pneumonia in patients with clinically amyopathic dermatomyositis with anti-MDA5 antibody

inferredcites →https://doi.org/10.1136/annrheumdis-2017-212149openalex-snapshot

Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis

inferredcites →https://doi.org/10.1136/annrheumdis-2018-215004openalex-snapshot

Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis

inferredcites →https://doi.org/10.1136/annrheumdis-2019-215046openalex-snapshot

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

inferredcites →https://doi.org/10.1136/annrheumdis-2020-217953openalex-snapshot

Response to: ‘Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort’ by Costa et al

inferredcites →https://doi.org/10.1136/annrheumdis-2020-218594openalex-snapshot

Similarities and differences between severe COVID-19 pneumonia and anti-MDA-5-positive dermatomyositis-associated rapidly progressive interstitial lung diseases: a challenge for the future

inferredcites →https://doi.org/10.1136/rmdopen-2020-001202openalex-snapshot

Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease

inferredcites →https://doi.org/10.1155/2014/290797openalex-snapshot

Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis

inferredcites →https://doi.org/10.1172/jci129301openalex-snapshot

Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases

inferredcites →https://doi.org/10.1177/0961203316651748openalex-snapshot

Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease

inferredcites →https://doi.org/10.1183/13993003.01618-2020openalex-snapshot

Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?

inferredcites →https://doi.org/10.1186/1471-2474-11-223openalex-snapshot

Myositis autoantibodies in Korean patients with inflammatory myositis: Anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis

inferredcites →https://doi.org/10.1186/ar3547openalex-snapshot

Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan

inferredcites →https://doi.org/10.1186/ar4600openalex-snapshot

Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study

inferredcites →https://doi.org/10.1186/s12890-017-0479-2openalex-snapshot

Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias

inferredcites →https://doi.org/10.1186/s13075-020-02160-9openalex-snapshot

Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies

inferredcites →https://doi.org/10.1186/s13613-018-0433-3openalex-snapshot

Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study

inferredcites →https://doi.org/10.1212/wnl.0000000000009727openalex-snapshot

Different phenotypes in dermatomyositis associated with anti-MDA5 antibody

inferredcites →https://doi.org/10.1371/journal.pone.0154285openalex-snapshot

Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies

inferredcites →https://doi.org/10.1371/journal.pone.0234523openalex-snapshot

Evaluation of usefulness in surfactant protein D as a predictor of mortality in myositis-associated interstitial lung disease

inferredcites →https://doi.org/10.1378/chest.13-0186openalex-snapshot

Successful Polymyxin B Hemoperfusion Treatment Associated With Serial Reduction of Serum Anti-CADM-140/MDA5 Antibody Levels in Rapidly Progressive Interstitial Lung Disease With Amyopathic Dermatomyositis

inferredcites →https://doi.org/10.2169/internalmedicine.56.7956openalex-snapshot

Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Treated with Rituximab: A Report of 3 Cases in Japan

inferredcites →https://doi.org/10.3109/14397595.2013.844390openalex-snapshot

Serum interleukin 6 levels as a useful prognostic predictor of clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease

inferredcites →https://doi.org/10.3389/fimmu.2019.00848openalex-snapshot

Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies

inferredcites →https://doi.org/10.3892/ol.2018.9409openalex-snapshot

Characteristics and predictors of malignancy in dermatomyositis: Analysis of 239 patients from northern China

inferredcites →https://doi.org/10.3899/jrheum.160682openalex-snapshot

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis

inferredcites →https://doi.org/10.3899/jrheum.170165openalex-snapshot

HLA-DRB1 Alleles as Genetic Risk Factors for the Development of Anti-MDA5 Antibodies in Patients with Dermatomyositis

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4017005openalex-extracted

Diagnostic Challenge of Anti-MDA5 Myositis with Respiratory Failure During COVID-19 Pandemic

inferred← citeshttps://doi.org/10.1001/jamadermatol.2024.0507openalex-snapshot

Assessing Time of Onset for Interstitial Lung Disease in Anti-MDA5 Antibody-Positive Dermatomyositis

inferred← citeshttps://doi.org/10.1002/acr.25525openalex-snapshot

Racial, Ethnic, Sex, and Geographical Diversity in Myositis Clinical Trials

inferred← citeshttps://doi.org/10.1002/ccr3.9573openalex-snapshot

Anti–Melanoma Differentiation Associated Gene 5 (MDA 5) Dermatomyositis Complicated by Spontaneous Pneumomediastinum: A Case Report From South Africa

inferred← citeshttps://doi.org/10.1007/s00296-021-04897-1openalex-snapshot

Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study

inferred← citeshttps://doi.org/10.1007/s00296-022-05149-6openalex-snapshot

Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review

inferred← citeshttps://doi.org/10.1007/s00296-022-05176-3openalex-snapshot

New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review

inferred← citeshttps://doi.org/10.1007/s00296-024-05683-5openalex-snapshot

Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports

inferred← citeshttps://doi.org/10.1007/s00393-025-01627-xopenalex-snapshot

Sequenzielle Autoimmunität? Der seltene Fall einer MDA5-Dermatomyositis und Sarkoidose

inferred← citeshttps://doi.org/10.1007/s10067-022-06401-xopenalex-snapshot

Cardiac involvement in anti-MDA5 dermatomyositis: a case-based review

inferred← citeshttps://doi.org/10.1007/s10067-024-07224-8openalex-snapshot

Dactylitis in Melanoma Differentiation–Associated protein 5 (MDA5)-associated amyopathic dermatomyositis: clue or conundrum?

inferred← citeshttps://doi.org/10.1007/s10067-025-07351-wopenalex-snapshot

Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease masquerading as rheumatoid arthritis-associated interstitial lung disease or overlapping with the same: a phenomenon driven by a probable genetic predisposition

inferred← citeshttps://doi.org/10.1007/s10067-025-07562-1openalex-snapshot

Coexistence of anti-melanoma differentiation-associated protein 5 and anti-Ro52 antibodies in patients with idiopathic inflammatory myopathy: a retrospective cohort study

inferred← citeshttps://doi.org/10.1007/s11606-024-08866-9openalex-snapshot

Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis Without Cutaneous Findings or Rapidly Progressive Lung Disease: A Case Report

inferred← citeshttps://doi.org/10.1007/s42399-022-01357-0openalex-snapshot

A Rare Case of MDA-5-Positive Amyopathic Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Following COVID-19 mRNA Vaccination — a Case Report

inferred← citeshttps://doi.org/10.1016/b978-0-443-18566-3.00016-5openalex-snapshot

Setting a context for autoantibodies, autoimmunity, and autoimmune diseases associated with SARS-CoV2

inferred← citeshttps://doi.org/10.1016/b978-0-443-23947-2.00022-9openalex-snapshot

The autoimmune myopathies

inferred← citeshttps://doi.org/10.1016/j.amjms.2022.12.001openalex-snapshot

Clinical and HRCT features of amyopathic dermatomyositis associated with interstitial lung disease: A retrospective study of 128 patients with connective tissue disease-related interstitial lung disease

inferred← citeshttps://doi.org/10.1016/j.bdcasr.2025.100123openalex-snapshot

New onset of juvenile dermatomyositis after COVID-19 infection in two patients: a case report

inferred← citeshttps://doi.org/10.1016/j.berh.2022.101769openalex-snapshot

Management of interstitial lung disease (ILD) in myositis syndromes: A practical guide for clinicians

inferred← citeshttps://doi.org/10.1016/j.imlet.2024.106966openalex-snapshot

Seasonal patterns of myositis-specific and myositis-associated autoantibodies in Italy

inferred← citeshttps://doi.org/10.1016/j.jaad.2022.07.010openalex-snapshot

Disease flare in patients with dermatomyositis following COVID-19 vaccination

inferred← citeshttps://doi.org/10.1016/j.jaut.2023.103095openalex-snapshot

Environmental exposures as risk factors for idiopathic inflammatory myopathies

inferred← citeshttps://doi.org/10.1016/j.jdcr.2025.02.023openalex-snapshot

Anti-MDA-5 dermatomyositis with tumid lupus-like lesions

inferred← citeshttps://doi.org/10.1016/j.jtauto.2026.100353openalex-snapshot

How loss-of-function mutations in IFIH1 contribute to infectious and/or inflammatory disease – a systematic review

inferred← citeshttps://doi.org/10.1016/j.rcreu.2021.06.001openalex-snapshot

Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review

inferred← citeshttps://doi.org/10.1016/j.rcreue.2021.06.012openalex-snapshot

Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review

inferred← citeshttps://doi.org/10.1016/j.revmed.2021.10.186openalex-snapshot

Dermatomyositis following COVID-19 infection

inferred← citeshttps://doi.org/10.1016/j.rmcr.2024.102098openalex-snapshot

A 72-year-old man with acute lung injury and anti-melanoma differentiation-associated gene 5 antibody: A case report

inferred← citeshttps://doi.org/10.1016/j.rmed.2023.107322openalex-snapshot

Serum IgA levels for predicting the development of rapidly progressive interstitial lung disease in dermatomyositis

inferred← citeshttps://doi.org/10.1016/j.semarthrit.2022.151959openalex-snapshot

Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review

inferred← citeshttps://doi.org/10.1016/j.semarthrit.2022.152034openalex-snapshot

COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis

inferred← citeshttps://doi.org/10.1016/s2213-2600(24)00267-4openalex-snapshot

Idiopathic inflammatory myopathies related lung disease in adults

inferred← citeshttps://doi.org/10.1016/s2665-9913(23)00322-3openalex-snapshot

Idiopathic inflammatory myopathies: current insights and future frontiers

inferred← citeshttps://doi.org/10.1038/s41390-024-03551-3openalex-snapshot

Profile of patients with Juvenile Dermatomyositis and Anti-MDA5 autoantibodies

inferred← citeshttps://doi.org/10.1038/s41409-022-01730-6openalex-snapshot

Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation

inferred← citeshttps://doi.org/10.1038/s41584-023-01033-0openalex-snapshot

Epidemiology of the idiopathic inflammatory myopathies

inferred← citeshttps://doi.org/10.1080/14656566.2024.2392021openalex-snapshot

Current evidence for janus kinase inhibitors in adult and juvenile dermatomyositis and key comparisons

inferred← citeshttps://doi.org/10.1080/1744666x.2023.2212162openalex-snapshot

Clinical pearls and promising therapies in myositis

inferred← citeshttps://doi.org/10.1093/jalm/jfac038openalex-snapshot

The Utility of Myositis Specific Antibodies in Clinical Practice

inferred← citeshttps://doi.org/10.1093/omcr/omae061openalex-snapshot

Two challenging cases of anti-MDA-5 dermatomyositis with rapidly progressive interstitial lung disease

inferred← citeshttps://doi.org/10.1093/rheumatology/kead638openalex-snapshot

Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease

inferred← citeshttps://doi.org/10.1093/rheumatology/keae167openalex-snapshot

Assessing the sensitivity and specificity of myositis-specific and associated autoantibodies: a sub-study from the MyoCite cohort

inferred← citeshttps://doi.org/10.1093/rheumatology/keae614openalex-snapshot

Inclusion body myositis and immunosenescence: current evidence and future perspectives

inferred← citeshttps://doi.org/10.1097/bor.0000000000000844openalex-snapshot

Environmental triggers for connective tissue disease: the case of COVID-19 associated with dermatomyositis-specific autoantibodies

inferred← citeshttps://doi.org/10.1097/bor.0000000000000908openalex-snapshot

Anti-MDA5 dermatomyositis: an update from bench to bedside

inferred← citeshttps://doi.org/10.1097/bor.0000000000001184openalex-snapshot

Environmental exposures and risks for the idiopathic inflammatory myopathies and its phenotypes: a narrative review

inferred← citeshttps://doi.org/10.1111/1756-185x.14608openalex-snapshot

Other iatrogenic immunodeficiency‐associated lymphoproliferative disorders in a patient with anti‐melanoma differentiation‐associated gene 5‐positive dermatomyositis: A case report and systematic literature review

inferred← citeshttps://doi.org/10.1111/1756-185x.14788openalex-snapshot

Other iatrogenic immunodeficiency‐associated lymphoproliferative disorders in anti‐melanoma differentiation‐associated protein 5 associated myositis—Truly iatrogenic or primary immunodeficiency?

inferred← citeshttps://doi.org/10.1111/1756-185x.14901openalex-snapshot

Treating dermatomyositis anti‐melanoma differentiation‐associated gene 5 antibody disease. A true rheumatologic urgency

inferred← citeshttps://doi.org/10.1111/1756-185x.15438openalex-snapshot

ADA2 Levels in Anti‐ MDA ‐5‐Positive Idiopathic Inflammatory Myopathies in the MyoCite Cohort

inferred← citeshttps://doi.org/10.1111/jpc.70256openalex-snapshot

MDA5 Antibody Associated Juvenile Dermatomyositis Presenting as Rapidly Progressive Pulmonary Fibrosis—Case Report

inferred← citeshttps://doi.org/10.1136/bcr-2023-259338openalex-snapshot

Anti-melanoma differentiation-associated gene 5 (anti-MDA5) positive dermatomyositis: early detection is crucial

inferred← citeshttps://doi.org/10.1155/2022/1107673openalex-snapshot

Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis

inferred← citeshttps://doi.org/10.1177/03946320241260295openalex-snapshot

Prevalence of cutaneous manifestations and myositis-specific antibodies in COVID-19 patients and Anti-PL7 antibodies association with pulmonary radiological severity: A retrospective study

inferred← citeshttps://doi.org/10.1186/s12890-025-03512-4openalex-snapshot

Neutrophil-to-lymphocyte ratio and short-term mortality in patients having anti-MDA5-positive dermatomyositis with interstitial lung disease: a retrospective study

inferred← citeshttps://doi.org/10.1186/s13256-024-04793-9openalex-snapshot

Management of anti-melanoma differentiation-associated gene 5 antibody-induced refractory dermatomyositis complicated by interstitial pneumonia using tofacitinib and its outcomes: a case report

inferred← citeshttps://doi.org/10.1186/s13256-025-05336-6openalex-snapshot

Anti-melanoma differentiation-associated gene 5 antibody associated rapidly progressive interstitial lung disease in a pediatric patient: a case report

inferred← citeshttps://doi.org/10.12680/balneo.2022.562openalex-snapshot

Particularities regarding Clinical-biological and Evolutive Parameters of Immune-mediated Rheumatic Diseases in Patients with COVID-19 – systematic literature review

inferred← citeshttps://doi.org/10.12680/balneo.2023.562openalex-snapshot

Particularities regarding Clinical-biological and Evolutive Parameters of Immune-mediated Rheumatic Diseases in Patients with COVID-19 – systematic literature review

inferred← citeshttps://doi.org/10.12688/wellcomeopenres.18728.1openalex-snapshot

Case Report: Anti-MDA-5 dermatomyositis in a resource-limited setting

inferred← citeshttps://doi.org/10.12890/2021_002860openalex-snapshot

Skin Rash and Interstitial Pneumonia Can Be a Fatal Combination: A Rare Case of Anti-Melanoma Differentiation-Associated Gene 5 (MDA5)-Associated Interstitial Lung Disease

inferred← citeshttps://doi.org/10.13175/swjpcc023-21openalex-snapshot

July 2021 Critical Care Case of the Month: When a Chronic Disease Becomes Acute

inferred← citeshttps://doi.org/10.15690/vramn18194openalex-snapshot

Assessing the role of interferons in congenital and acquired interferonopathies: a review

inferred← citeshttps://doi.org/10.21203/rs.3.rs-3707413/v1openalex-snapshot

Comparison of chest radiological findings between coronavirus disease 2019 pneumonia and anti-melanoma differentiation-associated gene 5 antibody- positive interstitial pneumonia by artificial intelligence-based quantitative computed tomography image analysis

inferred← citeshttps://doi.org/10.2147/jir.s369477openalex-snapshot

Dermatomyositis Flare After a COVID-19 Infection Successfully Treated with Rituximab: A Case Report and Literature Review

inferred← citeshttps://doi.org/10.2169/internalmedicine.5163-24openalex-snapshot

New-onset Anti-melanoma Differentiation-associated Gene 5 Antibody Positive Clinically Amyopathic Dermatomyositis Following COVID-19

inferred← citeshttps://doi.org/10.2217/fvl-2021-0146openalex-snapshot

Clinical Course of Idiopathic Inflammatory Myopathies in the COVID-19 Pandemic: A single-center Experience

inferred← citeshttps://doi.org/10.25251/d23n2w19openalex-snapshot

Clue to Diagnosis: Flagellate Erythema in Anti-MDA5 Antibody-Positive Dermatomyositis in a Patient with Skin of Color

inferred← citeshttps://doi.org/10.25259/jch_55_2024openalex-snapshot

Anti-melanoma Differentiation-Associated Gene 5 Dermatomyositis with Rapidly Progressive Interstitial Lung Disease: A Case of Rapidly Developing Shortness of Breath

inferred← citeshttps://doi.org/10.31138/mjr.191123.cuaopenalex-snapshot

Cutaneous Ulcers and Response to Treatment in a Child with Anti-MDA5 Dermatomyositis

inferred← citeshttps://doi.org/10.32677/ijcr.v8i10.3662openalex-snapshot

A vexing case of non-healing ulcers with interstitial lung disease

inferred← citeshttps://doi.org/10.3389/fimmu.2021.747116openalex-snapshot

COVID-19 Disease and Dermatomyositis: A Mini-Review

inferred← citeshttps://doi.org/10.3389/fimmu.2022.1002329openalex-snapshot

New-onset dermatomyositis following COVID-19: A case report

inferred← citeshttps://doi.org/10.3389/fimmu.2022.937667openalex-snapshot

Anti-MDA5 Antibody Linking COVID-19, Type I Interferon, and Autoimmunity: A Case Report and Systematic Literature Review

inferred← citeshttps://doi.org/10.3389/fimmu.2023.1197493openalex-snapshot

Deciphering the crosstalk of immune dysregulation between COVID-19 and idiopathic inflammatory myopathy

inferred← citeshttps://doi.org/10.3389/fimmu.2023.1249844openalex-snapshot

Transcriptomic profiling and longitudinal study reveal the relationship of anti-MDA5 titer and type I IFN signature in MDA5+ dermatomyositis

inferred← citeshttps://doi.org/10.3389/fimmu.2024.1394690openalex-snapshot

Undercover lung damage in pediatrics - a hot spot in morbidity caused by collagenoses

inferred← citeshttps://doi.org/10.3389/fimmu.2025.1565803openalex-snapshot

Anti-MDA5+ dermatomyositis following SARS-COV-2 infections: a systematic review

inferred← citeshttps://doi.org/10.3389/fimmu.2025.1628928openalex-snapshot

Associated factors in the development of rapidly progressive interstitial lung disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis

inferred← citeshttps://doi.org/10.3389/fimmu.2026.1817318openalex-snapshot

Case Report: Lung transplantation for rare anti-MDA5–positive rapidly progressive interstitial lung disease: two cases and a narrative review

inferred← citeshttps://doi.org/10.3389/fimmu.2026.1867606openalex-snapshot

A transfer learning-based multimodal model for early prediction of 90-day respiratory failure in dermatomyositis-associated interstitial lung disease

inferred← citeshttps://doi.org/10.3389/fmed.2022.1065960openalex-snapshot

Retinal changes in patients with idiopathic inflammatory myopathies: A case-control study in the MyoCite cohort

inferred← citeshttps://doi.org/10.3389/fmed.2023.1165225openalex-snapshot

Interferon and autoantigens: intersection in autoimmunity

inferred← citeshttps://doi.org/10.3390/antib15020024openalex-snapshot

Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel Observation

inferred← citeshttps://doi.org/10.3390/biomedicines12122800openalex-snapshot

Increased Risk of Myositis-Specific and Myositis-Associated Autoantibodies After COVID-19 Pandemic and Vaccination: A Spanish Multicenter Collaborative Study

inferred← citeshttps://doi.org/10.3390/diagnostics15030275openalex-snapshot

Recognition of Idiopathic Inflammatory Myopathies Underlying Interstitial Lung Diseases

inferred← citeshttps://doi.org/10.3390/jor6030022openalex-snapshot

Interstitial Lung Disease (ILD) in Immune Inflammatory Myopathies—A Comprehensive Review Focusing on ILD in Antisynthetase Syndrome and MDA5 Dermatomyositis

inferred← citeshttps://doi.org/10.3390/life12081108openalex-snapshot

Anti-MDA5 Amyopathic Dermatomyositis—A Diagnostic and Therapeutic Challenge

inferred← citeshttps://doi.org/10.3390/medicina58121757openalex-snapshot

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis

inferred← citeshttps://doi.org/10.3390/rheumato4010004openalex-snapshot

A Review of MDA-5 Dermatomyositis and Associated Interstitial Lung Disease

inferred← citeshttps://doi.org/10.34117/bjdv9n5-140openalex-snapshot

Dermatomiosite juvenil: epidemiologia, manifestações clínicas e manejo terapêutico

inferred← citeshttps://doi.org/10.37811/cl_rcm.v7i1.4674openalex-snapshot

Relación del covid – 19 y la dermatomiositis asociada al anticuerpo anti – MDA-5

inferred← citeshttps://doi.org/10.4081/reumatismo.2026.1826openalex-snapshot

Concurrent herpetic hypertensive anterior uveitis and cytomegalovirus retinitis in a non-HIV patient with melanoma differentiation-associated gene-5 dermatomyositis: intravenous immunoglobulin comes to the rescue

inferred← citeshttps://doi.org/10.4103/ara.ara_31_25openalex-snapshot

Clinical Characteristics, Management, and Outcomes of Patients with MDA5-associated Rapidly Progressive Interstitial Lung Disease: A Single-center Observational Study from Qatar

inferred← citeshttps://doi.org/10.4103/idoj.idoj_416_21openalex-snapshot

Knuckle lesions in inherited and acquired disorders

inferred← citeshttps://doi.org/10.4103/injr.injr_139_22openalex-snapshot

Clinical Characteristics, Therapeutics, and Treatment Outcomes of Adult Patients with Anti-Melanoma Differentiation-Associated gene 5 Dermatomyositis: A Single-Center Experience from South India

inferred← citeshttps://doi.org/10.4103/injr.injr_76_22openalex-snapshot

Autoinflammation and Autoimmunity: More to What Meets the Eye

inferred← citeshttps://doi.org/10.4103/injr.injr_92_21openalex-snapshot

Hyperpigmentation Heralding Relapse of Active Dermatomyositis in an Indian Patient

inferred← citeshttps://doi.org/10.4103/jewd.jewd_36_22openalex-snapshot

Dermatomyositis

inferred← citeshttps://doi.org/10.4236/ojra.2025.152008openalex-snapshot

Viral Myositis and Dermatomyositis: Key Diagnostic Differences

inferred← citeshttps://doi.org/10.5114/reum/201151openalex-snapshot

Different faces of anti-melanoma differentiation-associated gene 5 antibody-positive myositis

inferred← citeshttps://doi.org/10.55563/clinexprheumatol/mkfmxtopenalex-snapshot

Skeletal muscles and Covid-19: a systematic review of rhabdomyolysis and myositis in SARS-CoV-2 infection

inferred← citeshttps://doi.org/10.7759/cureus.111003openalex-snapshot

An Aggressive Presentation of Anti-melanoma Differentiation-Associated Gene 5 (MDA-5)-Positive Dermatomyositis With Rapidly Progressive Interstitial Lung Disease: A Case Report

inferred← citeshttps://doi.org/10.7759/cureus.23102openalex-snapshot

Anti-melanoma Differentiation-Associated Gene 5 (Anti-MDA5) Dermatomyositis: A Case Presentation

inferred← citeshttps://doi.org/10.7759/cureus.34235openalex-snapshot

Dermatomyositis With Dual Positive Anti-melanoma Differentiation-Associated Gene 5 and Anti-Sjogren Syndrome-Related Antigen 52 kD Antibodies: A Case Report and Literature Review on Clinical Characteristics

inferred← citeshttps://doi.org/10.7759/cureus.90433openalex-snapshot

Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis With Rapidly Progressive Interstitial Lung Disease Complicated by Pneumothorax, Pneumomediastinum, and Subcutaneous Emphysema: Clinical Course Compared With Reported Cases Worldwide

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.